Diagnostic and prognostic tests in systemic lupus erythematosus
- PMID: 29224677
- PMCID: PMC5776716
- DOI: 10.1016/j.berh.2017.10.002
Diagnostic and prognostic tests in systemic lupus erythematosus
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease characterized by autoantibodies directed against numerous self-nuclear antigens. Because of the heterogeneous nature of lupus, it has been challenging to identify markers that are sensitive and specific enough for its diagnosis and monitoring. However, with the sequencing of the human genome, rapid development of high-throughput approaches has allowed for a better understanding of the etiopathogenesis of complex diseases, including SLE. Here we present a review of the latest advancements in biomarker discovery during the "omics" era, using these novel technologies, for assisting in the diagnosis and prognosis of patients with SLE.
Keywords: Biomarkers; Epigenetics; Genomics; Lupus nephritis; Metabolomics; Proteomics; Systemic lupus erythematosus; Transcriptomics.
Copyright © 2017 Elsevier Ltd. All rights reserved.
References
-
- Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110–21. - PubMed
-
- Bonanni A, et al. Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference. Autoimmun Rev. 2015;14(8):692–702. - PubMed
-
- Calvo-Alen J, et al. Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center. Arthritis Rheum. 1995;38(10):1475–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources